Appears on
Articles5
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an experimental vaccine targeting mutant KRAS, one of the most common genetic drivers of pancreatic cancer, was safe and generated durable immune responses aimed at preventing the cancer in people at high risk.
Virtual Tumor Predict Response to Liver Cancer Immunotherapy
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular carcinoma (HCC) would most benefit from combination treatment using immunotherapy and a targeted therapy that blocks the grow
Newly Identified Inhibitors May Boost Chemotherapy Drug's Ability to Fight Treatment-Resistant Cancers
In a new report of research, scientists at Johns Hopkins University School of Medicine and Johns Hopkins Kimmel Cancer Center say they have found a potential therapeutic target that can boost the potency of a chemotherapy used to treat certain cancers.
Machine Learning Method Enables Easier and Wider Use of Martin-Hopkins Equation to Accurately Assess LDL Cholesterol Risk
The Martin-Hopkins equation to assess low-density lipoprotein (LDL) cholesterol levels in blood samples has been used by laboratories in the U.S. and other countries to guide efforts to lower cardiovascular disease risk.
Multicenter Study Provides New Insight to Guide Future Rehabilitation and Nutrition Strategies for ICU Patients
A new national clinical trial, funded by the National Institutes of Health, is helping reshape the future of recovery research for critically ill patients, providing important new evidence about how rehabilitation and nutrition interventions should be delivered during severe illness and informing the next generation of research to improve ICU survivors' outc